Patent ID: 9737550
Date: 2017-08-22
CPC Classifications: A61K,A61P

Claim:
1. A method for treating nasal decongestion in a human or other animal subject, comprising administering to the subject a nasal spray composition consisting of oxymetazoline, a nasal corticosteroid, and a liquid pharmaceutically-acceptable carrier, in one or more doses, wherein each dose consists of one or more sprays of the composition in one or both nostrils of the subject, the amount of oxymetazoline administered to a nostril in each dose is about 25 μg to about 100 μg, the amount of the nasal corticosteroid administered to a nostril in each dose is about 25 μg to about 130 μg, the daily dosage of the oxymetazoline is from about 50 μg to about 400 μg, the daily dosage of the nasal corticosteroid is from about 50 μg to about 450 μg, and the amounts of the oxymetazoline and of the nasal corticosteroid are synergistic.